May 10, 2017 / 12:24 PM / 3 months ago

BRIEF-Argos therapeutics provides update on ADAPT trial following meeting with FDA

May 10 (Reuters) - Argos Therapeutics Inc

* Argos provides update on its ADAPT trial following meeting with FDA

* Argos Therapeutics Inc- FDA agreed with company's plan to continue trial in accordance with current protocol to 290 events

* Argos Therapeutics - FDA agreed to review, protocol amendment to increase pre-specified number of events for primary analysis of OS beyond 290 events

* Argos - submitted information on analysis of interim data to fda, met to discuss future direction of ADAPT trial, rocapuldencel-t development program Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below